Ausgabe 4/2012
Inhalt (11 Artikel)
Beyond Hyperglycemia in Diabetes: Role of Statin Treatment on Thrombogenesis Triggered by Inflammation
Francesca Perego, Giovanni Davì
Relaxant Effect of a Water Soluble Carbon Monoxide-Releasing Molecule (CORM-3) on Spontaneously Hypertensive Rat Aortas
Paola Failli, Alfredo Vannacci, Lorenzo Di Cesare Mannelli, Roberto Motterlini, Emanuela Masini
Statin-Induced Immunomodulation Alters Peripheral Invariant Natural Killer T-cell Prevalence in Hyperlipidemic Patients
Evangelia Nakou, Prodromos Babageorgakas, Irene Bouchliou, Dimitrios N. Tziakas, Paraskevi Miltiades, Emmanouil Spanoudakis, Dimitrios Margaritis, Ioannis Kotsianidis, Dimitrios A. Stakos
Impact of Statins on the Coagulation Status of Type 2 Diabetes Patients Evaluated by a Novel Thrombin-Generation Assay
P. Ferroni, D. Della-Morte, A. Pileggi, M. G. Valente, F. Martini, F. La Farina, R. Palmirotta, L. F. Meneghini, T. Rundek, C. Ricordi, F. Guadagni
The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes
Pedram Kazemian, Seyyed M. R. Kazemi-Bajestani, Aws Alherbish, Justin Steed, Gavin Y. Oudit
High Molecular Weight Calmodulin-Binding Protein: 20 Years Onwards—A Potential Therapeutic Calpain Inhibitor
Sreejit Parameswaran, Rajendra K. Sharma
Importance of Blood Rheology in the Pathophysiology of Atherothrombosis
Aimee Q. Cowan, Daniel J. Cho, Robert S. Rosenson
Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
Michael Davidson, Robert S. Rosenson, Kevin C. Maki, Stephen J. Nicholls, Christie M. Ballantyne, Carolyn Setze, Dawn M. Carlson, James Stolzenbach
New Challenges Ahead for the Newer Oral Thrombin Inhibitors that Aim at Replacing Warfarin in Clinical Practice—Any Role for Scientific Societies in the Debate?
Juan-Carlos Kaski